Published : 27 Mar 2015
An Indian private limited Biotech company has appointed Aagami to help them find the right Strategic Investor or Joint Venture Partner, to commercialise their patented technology for manufacturing Algal DHA.
As a part of the assignment, Aagami will identify potential investors and JV partners from India as well as US, using Aagami’s strong network and deal making experience in the regions.
Granted patent in the US, India and EU (PCT published), client technology is Ingenious, with high yield strain and low cost of raw material. The end product quality of the lab scale production (1000 batches) has been certified by independent third party agencies.
Aagami is confident of completing this assignment successfully within a few months. Any companies who wish to know more about this Algal DHA technology may write to godwyn@aagami.com or call +1-630-364-1837.